TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

ACARBOSE

ACARBOSE alpha Glucosidase Inhibitors
Metabolic Approved 2008-05-07
7
Indications
--
Phase 3 Trials
17
Years on Market

Details

Status
Prescription
First Approved
2008-05-07
Routes
ORAL
Dosage Forms
TABLET

ACARBOSE Approval History

Loading approval history...

What ACARBOSE Treats

1 indications

ACARBOSE is approved for 1 conditions since its original approval in 2008. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Type 2 Diabetes
Source: FDA Label

Drugs Similar to ACARBOSE

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ACTOS
PIOGLITAZONE HYDROCHLORIDE
1 shared
Takeda
Shared indications:
Type 2 Diabetes
ADLYXIN
LIXISENATIDE
1 shared
SANOFI-AVENTIS US
Shared indications:
Type 2 Diabetes
ATORVALIQ
ATORVASTATIN CALCIUM
1 shared
CMP DEV LLC
Shared indications:
Type 2 Diabetes
BASAGLAR
INSULIN GLARGINE
1 shared
Eli Lilly
Shared indications:
Type 2 Diabetes
BRENZAVVY
BEXAGLIFLOZIN
1 shared
THERACOSBIO
Shared indications:
Type 2 Diabetes
BRYNOVIN
SITAGLIPTIN HYDROCHLORIDE
1 shared
AZURITY
Shared indications:
Type 2 Diabetes
CADUET
AMLODIPINE BESYLATE
1 shared
PHARMACIA
Shared indications:
Type 2 Diabetes
COZAAR
LOSARTAN POTASSIUM
1 shared
Merck
Shared indications:
Type 2 Diabetes
CYCLOSET
BROMOCRIPTINE MESYLATE
1 shared
VEROSCIENCE
Shared indications:
Type 2 Diabetes
DIABETA
GLYBURIDE
1 shared
Sanofi
Shared indications:
Type 2 Diabetes
DUETACT
GLIMEPIRIDE
1 shared
Takeda
Shared indications:
Type 2 Diabetes
FARXIGA
DAPAGLIFLOZIN
1 shared
AstraZeneca
Shared indications:
Type 2 Diabetes
GLYBURIDE
GLYBURIDE
1 shared
IMPAX LABS INC
Shared indications:
Type 2 Diabetes
GLYXAMBI
EMPAGLIFLOZIN
1 shared
Boehringer Ingelheim
Shared indications:
Type 2 Diabetes
INPEFA
SOTAGLIFLOZIN
1 shared
LEXICON PHARMS INC
Shared indications:
Type 2 Diabetes
INVOKAMET
CANAGLIFLOZIN
1 shared
Johnson & Johnson
Shared indications:
Type 2 Diabetes
INVOKAMET XR
CANAGLIFLOZIN
1 shared
Johnson & Johnson
Shared indications:
Type 2 Diabetes
JANUMET
METFORMIN HYDROCHLORIDE
1 shared
Merck
Shared indications:
Type 2 Diabetes
JANUMET XR
METFORMIN HYDROCHLORIDE
1 shared
Merck
Shared indications:
Type 2 Diabetes
JANUVIA
SITAGLIPTIN PHOSPHATE
1 shared
Merck
Shared indications:
Type 2 Diabetes
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ACARBOSE FDA Label Details

Pro

Indications & Usage

Acarbose tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.